Work

A phase 2 study of live-attenuated listeria monocytogenes cancer immunotherapy (ADXS11-001) in the treatment of persistent or recurrent cancer of the cervix (GOG-0265).

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.tps5617

Authors: Warner King Huh, William E. Brady, Kathleen N. Moore, Heather A. Lankes, Bradley J. Monk, Carol Aghajanian, Don S. Dizon, Deborah K Armstrong, Premal H. Thaker, Paula M. Fracasso

Institutions: University of Alabama at Birmingham, University of Oklahoma Health Sciences Center, Gynecologic Oncology Group, Creighton University, St. Joseph's Hospital and Medical Center, Memorial Sloan Kettering Cancer Center, Massachusetts General Hospital, Dana-Farber/Harvard Cancer Center, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Washington University in St. Louis, University of Virginia

Language: English

Topic: Cancer Research and Treatments

Subfield: Biotechnology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4253435379

Cites:

Cited by: 12

Related to: 10